Opko Health Inc OPK

NAS: OPK | ISIN: US68375N1037 17:15

1,580 USD (-1,25%)

(-1,25%) 17:15

Grafiek Opko Health Inc

Grafiek Opko Health Inc

1 dag1d -1,25%
1 week1w 3,27%
1 maand1m 17,91%
3 maanden3m -7,60%
6 maanden6m -2,47%
1 jaar1j 17,04%
5 jaar5j -52,41%

Opko Health Inc in het nieuws

Toon enkel gratis nieuws

7 november 2023 · BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™ · Persbericht

29 september 2023 · Thinking about buying stock in Blue Apron Holdings, OceanPal, OPKO Health, Bionomics, or Aytu Biopharma? · Persbericht

9 februari 2023 · BioReference Now Offers the Only FDA-Approved Dual-Stain Triage Test to Enhance Cervical Cancer Screenings · Persbericht

16 maart 2022 · GeneDx Announces Discovery of 200 New and Expanded Genetic Conditions · Persbericht

1 maart 2022 · Saol Therapeutics and GeneDx, Inc. Collaborate to Detect Patients with Rare Mitochondrial Disease · Persbericht

29 november 2021 · BioReference Laboratories Announces Readiness for COVID-19 Testing if the Omicron COVID-19 Variant Emerges in The U.S. · Persbericht

21 september 2021 · GeneDx Announces the Sequencing of More Than 300,000 Clinical Patient Exomes · Persbericht

16 augustus 2021 · BioReference Laboratories Acquires U.S. Ariosa Centralized Laboratory Prenatal Testing Business · Persbericht

22 juni 2021 · BioReference Laboratories Announces First COVID-19 Testing Program for Cruise Industry · Persbericht

27 april 2021 · Major League Soccer Renews with BioReference Laboratories as COVID-19 Testing Provider for Second Year · Persbericht

Profiel Opko Health Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: www.opko.com

Hoofdzetel: Miami, Florida Verenigde Staten

CEO: Phillip Frost

Werknemers: 339

Aandelen Opko Health Inc

Beurswaarde: 1,24 miljard USD

Effecten: 773,06 miljoen

Winst per aandeel (12 maand): PLUS

Beta: 1,47

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe